- Home
- HCWB vs SISI Comparison
HCWB vs SISI Comparison
Compare HCWB & SISI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HCWB
- SISI
- Stock Information
- Founded
- HCWB 2018
- SISI 1997
- Country
- HCWB United States
- SISI China
- Employees
- HCWB N/A
- SISI N/A
- Industry
- HCWB Biotechnology: Pharmaceutical Preparations
- SISI Medicinal Chemicals and Botanical Products
- Sector
- HCWB Health Care
- SISI Health Care
- Exchange
- HCWB Nasdaq
- SISI Nasdaq
- Market Cap
- HCWB 16.1M
- SISI 14.9M
- IPO Year
- HCWB 2021
- SISI 2016
- Fundamental
- Price
- HCWB $6.14
- SISI $0.44
- Analyst Decision
- HCWB Strong Buy
- SISI
- Analyst Count
- HCWB 1
- SISI 0
- Target Price
- HCWB $35.00
- SISI N/A
- AVG Volume (30 Days)
- HCWB 2.0M
- SISI 3.2M
- Earning Date
- HCWB 05-15-2025
- SISI 05-15-2025
- Dividend Yield
- HCWB N/A
- SISI N/A
- EPS Growth
- HCWB N/A
- SISI N/A
- EPS
- HCWB N/A
- SISI N/A
- Revenue
- HCWB $1,445,145.00
- SISI $9,601,324.00
- Revenue This Year
- HCWB N/A
- SISI N/A
- Revenue Next Year
- HCWB N/A
- SISI N/A
- P/E Ratio
- HCWB N/A
- SISI N/A
- Revenue Growth
- HCWB N/A
- SISI 1133.26
- 52 Week Low
- HCWB $5.00
- SISI $0.39
- 52 Week High
- HCWB $100.80
- SISI $117.65
- Technical
- Relative Strength Index (RSI)
- HCWB 36.95
- SISI 33.03
- Support Level
- HCWB $7.55
- SISI $0.67
- Resistance Level
- HCWB $8.75
- SISI $0.52
- Average True Range (ATR)
- HCWB 0.85
- SISI 0.08
- MACD
- HCWB -0.14
- SISI -0.03
- Stochastic Oscillator
- HCWB 4.60
- SISI 7.36
About HCWB HCW Biologics Inc.
HCW Biologics Inc is a clinical-stage biopharmaceutical company focused on discovering and developing novel immunotherapies to lengthen the health span by disrupting the link between chronic, low-grade inflammation and age-related diseases. The company has developed TOBI discovery platform, or Tissue factor-based fusion discovery platform, for the design of category-defining immunotherapeutic drugs. It has selected two molecules as its product candidate; HCW9218 and HCW9302. HCW9218 is a bifunctional immunotherapeutic designed with the capabilities to neutralize transforming growth and stimulate immune cells. HCW9302 is designed to activate and expand regulatory T cells, which deactivate inflammasomes.
About SISI Shineco Inc.
Shineco Inc aims to care for a healthy life and improve the quality of life by providing safe, efficient, and high-quality health products and services to society. The company has researched and developed various vitro diagnostic reagents and related medical devices to date, and it also produces and sells healthy and nutritious food.